Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
1
Tackling the challenges ahead
Sep 2009
Kurt Bock, CFOUBS Best of Germany Conference
New York, September 17, 2009
2
1 | Robust performance in difficult environment
2 | Managing the downturn
3 | Clear priorities for use of cash
3
Robust performance in challenging business environment
•
Cash generation remained strong; cost containment efforts show effects•
Earnings of chemical activities down; continued strong performance of Agricultural Solutions
•
High special charges of €300 million due to Ciba integration
Business development Q2 2009
Key figures Q2 2009 vs. Q2 2008•
Sales:
€12.5 billion (-23%)
•
EBIT before special items:
€1.1 billion (-53%)•
Net income:
€343 million (-74%)
•
Earnings per share:
€0.37 (-73%) Adjusted EPS: €0.79 (-49%)
•
Operating cash flow H1 2009:
€3.6 billion (+39%)
4
BASF today – a well-balanced portfolio Total sales 2008: €62.3 billion
* Styrenics
are reported under ‘Other’
following the transfer of the Specialty Plastics and Foams business units to the Performance Polymers division as of January 1, 2008
** Performance Products segment as of April 1, 2009 (not including Ciba)
Percentage of sales 2008
Chemicals
18%
Plastics*
15%
Functional Solutions15%
Performance Products**13%
Agricultural Solutions5%
Oil & Gas
23%
Construction
Chemicals
Inorganics
Petrochemicals
Intermediates
Performance
Chemicals
Coatings
Dispersions &
Pigments
Performance
Polymers
Polyurethanes
Crop
Protection
Exploration & Production
and
Natural Gas Trading
Care
Chemicals
Catalysts
Paper Chemicals
5
EBIT* before special items by activity in billion €without non-compensable foreign taxes on oil production
Oil & Gas and Agro businesses providing a stable earnings basis
* Without ‘Other’
** 2007 and 2008 according to new segment structure (excl. Styrenics
and corporate costs)
*** Based on German GAAP
0
1
2
3
4
5
6
7
2001*** 2002*** 2003*** 2004 2005 2006 2007** 2008**
Oil & GasAgroChemical activities
6
0
1
2
3
4
5
6
7
2004 2005 2006 2007** 2008**0
10
20
30
40
2004 2005 2006 2007** 2008**
Increasing share of specialty chemicals Development of sales and EBITDA
* Excluding Precious & Base Metal Services, Oil&Gas
and ‘Other’
** Excluding Styrenics
commodity business
Specialties Commodities
Sales in billion € * EBITDA in billion € *
48
52
49
51
49
51
49
51
53
47
52
48
53
47
55
45
63
37
62
38
7
50
100
150
200
250
2001 2002 2003 2004 2005 2006 2007 2008
Index
Fixed costs indexed
•
Absolute level of fixed costs stable compared to last trough, while business increased significantly
•
Acquisitions in 2006 pushed up fixed costs slightly
•
Fixed costs represent around 30% of total costs
EBITDA indexedSales indexed
Relentless fixed cost management
8
1 | Robust performance in difficult environment
2 | Managing the downturn
3 | Clear priorities for use of cash
9
•
Temporary shut-down or reduction of capacity of around 200 plants worldwide, reducing global capacity temporarily to slightly above 60%
•
Implementation of short-time work
•
Strict management of inventories and accounts receivable
Short-term measures
Longer-term measures
•
Continuous consolidation of production base
•
Synergies from efficient integration of acquisitions
•
Reduced capex
spending
•
Restructuring and efficiency program NEXT
Acting swiftly with focus on cost and cash
10
0
500
1,000
1,500
2,000
2,500
Annual earnings contribution in € million
Completed
restructuring
programs
NEXT
2003 2004 2006 2008
Sustainable improvement of cost base
2010 2012
NEXT
•
Project timeline:
2008 –
2011
•
Potential earnings contribution:
>€1 billion by 2012
•
Non-recurring costs: €300 million
•
Investment:
€700 million
•
Personnel reduction:
>1,000 employees
11
4 6 % *
Solid financing as a key advantage in turbulent times
100%BondsBonds •
Bonds for a total €4.0 billion and GBP400 million issued in 2009
•
Balanced bond maturity profile
•
Bonds for a total €4.0 billion and GBP400 million issued in 2009
•
Balanced bond maturity profile
CommercialPaperCommercialPaper
•
No difficulties in issuing commercial paper
•
Commercial paper program of $12.5 billion ($3.15 billion drawn by end of Q2 2009)
•
No difficulties in issuing commercial paper
•
Commercial paper program of $12.5 billion ($3.15 billion drawn by end of Q2 2009)
Syndicated LoansSyndicated Loans
•
Broadly syndicated undrawn long-term back-up lines of $6.0 billion
•
Short-term syndicated credit facility of CHF 3.5 billion
•
Broadly syndicated undrawn long-term back-up lines of $6.0 billion
•
Short-term syndicated credit facility of CHF 3.5 billion
CreditRatingCreditRating
•
Strong investment grade rating:
Moody‘s: A1/P-1 outlook stable; Standard & Poor’s:
A+/A-1 outlook negative
•
Committed to credit ratios that support a single A rating
•
Strong investment grade rating:
Moody‘s: A1/P-1 outlook stable; Standard & Poor’s:
A+/A-1 outlook negative
•
Committed to credit ratios that support a single A rating
12
1 | Robust performance in difficult environment
2 | Managing the downturn
3 | Clear priorities for use of cash
13
-1
0
1
2
3
4
5
6
2001** 2002** 2003** 2004 2005* 2006 2007 2008 H12009
Strong history of cash flow generation
In billion € Cash provided by operating activities Free cash flow*
* Cash provided by operating activities less capex
(in 2005 before CTA)
** According to German GAAP
2009
14
Focus on operating cash flow
R&D Capex Acquisitions Dividend
Stable Reduction of 20%
compared with 2008*Focus on Ciba
integration Increasingly difficult to
maintain dividend at €1.95
Reduction of net working capital by ~ €1 billion
Use of cash adapted to current market conditions
* Not including Ciba and Revus; Capex
2008: €2.5 billion
15
BASF’sposition
pre acquisition
Plastic additives 4 1
Coating effects materials 4 2
Paper chemicals 4 1
BASF has become the leading player in specialty chemicals
Position of combined businesses
16
Integration of Ciba’s business lines into BASF structure
Ciba businesses BASF division
Coatings Effects Dispersions & Pigments~ 1.1
2008 sales in billion €
Plastic AdditivesLubricant Additives
Water Treatment
Performance ChemicalsOilfield & Mining Chemicals
~ 1.6
Home & Personal Care Care Chemicals~ 0.3
Paper Paper Chemicals~ 0.9
Note: Expert Services will remain stand-alone unit
17
Extensive restructuring measures related to Ciba integration
•
Personnel–
Reduction of ~3,700 positions, majority of reductions by end of 2010
•
Production sites–
23 sites currently under strategic review, i.e. closure, divestiture or restructuring possible
–
32 production sites planned to be optimized and/or restructured, e.g. Bradford, Grenzach, Lampertheim and Maastricht
•
Non-production sites–
36 locations planned to be exited by 2010
Production sites under review by region
Headcount reduction by region
Americas4
Europe11
Asia8
Americas26%
Europe58%
Asia16%
18
Cost synergies related to Ciba integration
260
100
400
400
100
200
300
400
500
end 2009 end 2010 2011/2012 Steady State
Synergy ramp-up in million € Synergies in percent of sales (2008: €4.0 billion)
10Target: at least €400 million
Note: Ciba revenues 2008: CHF5,919 million or €3,986 million
≥ 5
0
7.5
2.5
Integration costs•
Total cash costs: ~€550 million (thereof €150 million in 2009)
•
Non-cash costs: ~ €
500 million
(thereof ~€400 million in 2009)
19
0,00
0,50
1,00
1,50
2,00
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Dividend in € per share •
CAGR of dividend (1999-2008): 15%
•
Attractive dividend yield of 6.8% in 2008*
Attractive shareholder return policy
*
Based on the share price of April 30, 2009 (€28.57)
Special dividendDividend
0
€1.95
20
Severe challenges for BASF in 2009
•
Basic assumptions for 2009•
Decline in
global gross domestic product (-3%)global industrial production (-10%)global chemical production excluding pharma
(-8%)
•
Average exchange rate of $1.35 per ۥ
Average oil price of $55/bbl
•
Outlook for 2009•
In view of the current economic environment and the expenses resulting from the Ciba integration, we anticipate a significant
decline in sales and earnings.•
Therefore, BASF is unlikely to earn its cost of capital in 2009.
21
Forward-looking statements
This presentation includes forward-looking statements that are subject to risks and uncertainties, including those pertaining to the anticipated benefits to be realized from the proposals described herein. This presentation contains a number of forward-looking statements including, in particular, statements about future events, future financial performance, plans, strategies, expectations, prospects, competitive environment, regulation and supply and demand. BASF has based these forward-looking statements on its views with respect to future events and financial performance. Actual financial performance of the entities described herein could differ materially from that projected in the forward-looking statements due to the inherent uncertainty of estimates, forecasts and projections, and financial performance may be better or worse than anticipated. Given these uncertainties, readers should not put undue reliance on any forward-looking statements.
Forward-looking statements represent estimates and assumptions only as of the date that they were made. The information contained in this presentation is subject to change without notice and BASF does not undertake any duty to update the forward-looking statements, and the estimates and assumptions associated with them, except to the extent required by applicable laws and regulations.
2222